Literature DB >> 26905590

PAQR3 enhances Twist1 degradation to suppress epithelial-mesenchymal transition and metastasis of gastric cancer cells.

Weiwei Guo1, Xue You2,3, Daqian Xu1, Yuxue Zhang1, Zheng Wang1, Kaiyang Man2,3, Zhenzhen Wang1, Yan Chen2,3.   

Abstract

Twist1 is an essential transcription factor required to initiate epithelial-mesenchymal transition (EMT) and promote tumor metastasis. PAQR3 is a newly found tumor suppressor that is frequently downregulated in many types of human cancers. Downregulation of PAQR3 is associated with accelerated metastasis and poor prognosis of the patients with gastric cancers. In this study, we demonstrate that PAQR3 is actively involved in the degradation of Twist1 and whereby regulates EMT and metastasis of gastric cancer cells. PAQR3 overexpression reduces the protein level but not the mRNA level of Twist1. The protein stability and polyubiquitination of Twist1 are altered by PAQR3. PAQR3 forms a complex with Twist1 and BTRC, an E3 ubiquitin ligase. PAQR3 enhances the interaction between Twist1 and BTRC. Twist1 is mobilized from the nucleus to a proteasome-containing structure in the cytoplasm upon overexpression of PAQR3 and BTRC, which is required for PAQR3-induced degradation of Twist1. The Twist1 box domain of the Twist1 protein is required for the interaction of Twist1 with both PAQR3 and BTRC, indispensable for PAQR3-mediated degradation of Twist1. Both BTRC and Twist1 are required for the inhibitory effects of PAQR3 on migration and EMT phenotype of gastric cancers cells. Importantly, Twist1 is indispensable for the inhibitory effect of PAQR3 on metastasis of gastric cancer cells in vivo Collectively, these findings not only pinpoint that Twist1 mediates the modulatory function of PAQR3 on EMT and metastasis but also suggest that targeting Twist1 is a promising strategy to control metastasis of tumors with downregulation of PAQR3.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26905590     DOI: 10.1093/carcin/bgw013

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

1.  ZNF451 stabilizes TWIST2 through SUMOylation and promotes epithelial-mesenchymal transition.

Authors:  Wang Zeng; Shuchen Gu; Yi Yu; Yili Feng; Mu Xiao; Xin-Hua Feng
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

Review 2.  Golgi Complex: A Signaling Hub in Cancer.

Authors:  Daniela Spano; Antonino Colanzi
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

3.  PRKCI Mediates Radiosensitivity via the Hedgehog/GLI1 Pathway in Cervical Cancer.

Authors:  Zhuna Wu; Chunxian Huang; Ruixin Li; Hui Li; Huaiwu Lu; Zhongqiu Lin
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

4.  miR-320 inhibited ovarian cancer oncogenicity via targeting TWIST1 expression.

Authors:  Chunyang Li; Ping Duan; Jianguang Wang; Xiaosheng Lu; Jing Cheng
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

5.  MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process.

Authors:  Youmao Tao; Songbai Yang; Yuanyu Wu; Xuedong Fang; Yannan Wang; Yan Song; Tao Han
Journal:  Oncotarget       Date:  2017-10-04

6.  GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.

Authors:  Dai Shimizu; Mitsuro Kanda; Haruyoshi Tanaka; Daisuke Kobayashi; Chie Tanaka; Masamichi Hayashi; Naoki Iwata; Yukiko Niwa; Hideki Takami; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

7.  High Expression of Peroxiredoxin 1 Is Associated with Epithelial-Mesenchymal Transition Marker and Poor Prognosis in Gastric Cancer.

Authors:  Wei Yu; Jing Wu; Zhong-Liang Ning; Qiao-Yu Liu; Rui-Liang Quan
Journal:  Med Sci Monit       Date:  2018-04-15

Review 8.  Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer.

Authors:  Weilin Li; Jennifer Mun-Kar Ng; Chi Chun Wong; Enders Kwok Wai Ng; Jun Yu
Journal:  Oncogene       Date:  2018-05-23       Impact factor: 9.867

9.  PAQR3 suppresses the proliferation, migration and tumorigenicity of human prostate cancer cells.

Authors:  Wenqiang Huang; Weiwei Guo; Xue You; Yi Pan; Zhenyang Dong; Gaozhen Jia; Chenghua Yang; Yan Chen
Journal:  Oncotarget       Date:  2016-06-03

10.  Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma.

Authors:  Ge Bai; Mei Yang; Chao Zheng; Li Zhang; Mayinur Eli
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.